Comparing the current results to its competitors, Avalon Globocare reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, faster than the overall decrease of Avalon Globocare's competitors by 0 %, recorded in the same quarter.
Avalon Globocare's Comment on Competition and Industry Peers
The company operates in two markets: consumer health technology and artificial intelligence content technology. In the consumer health technology segment, it offers the Keto Air Breathalyzer, competing with urine-based ketone test strips, which are the most common and lowest-cost ketosis measurement method. Competitors also include breath-based ketone monitors, such as earlier-generation breathalyzers requiring consumable cartridges and newer reusable breath ketone devices from other consumer health technology firms. The company is currently the sole seller of the Keto Air device in North America. Competitors generally have greater financial resources, brand recognition, and established retail distribution.
August 14, 2024
In a significant development for the medical technology sector, Avalon Laboratory Services, a subsidiary of Avalon Globocare Corp, is set to launch its proprietary FDA-registered external male catheter device. This product promises to provide an innovative solution for male urinary incontinence, a condition that affects millions of men, particularly those who are elderly or have undergone certain medical treatments. FDA Registration and Insurance Support The newly developed device has garnered FDA registration, which is a key approval that ensures its safety and effectiveness for consumer use. Importantly, the device is also approved for reimbursement by Medicare. This endorsement is crucial, as it enhances ...
July 31, 2024
Pioneering Health Innovations: Avalon GloboCare Launches Cutting-Edge DNA Testing Kit and KetoAir BreathalyzerIn a series of groundbreaking announcements, Avalon GloboCare Corp. (NASDAQ: ALBT), renowned for its innovative contributions to cell-based technology, cellular therapy, and precision diagnostics, has introduced two revolutionary health solutions. These advancements underscore the company s commitment to enhancing personal health management through innovative, non-invasive technologies. Avalon s DNA Testing Kit for Predisposition to Opioid AddictionAvalon GloboCare has launched a Direct-to-Consumer DNA testing kit designed to identify genetic predispositions to opioid addiction. This sophisticated, ...
July 18, 2024
The Innovative Leap in Keto Management: Avalon GloboCare s Launch of KetoAir Breathalyzer in the U.S. The management of ketogenic diets has increasingly become a focal point for many health-conscious individuals and practitioners aiming to optimize metabolic health, enhance mental clarity, and support weight management. As technology continues to advance, new tools are being developed to assist in this intricate nutritional process. Avalon GloboCare Corp. (NASDAQ: ALBT), a leader in innovative cell-based technology, cellular therapy, and precision diagnostics, has recently introduced a novel solution in this domain with the launch of the KetoAir breathalyzer. This paper explores the implications of Avalonâ...
Inhibrx Inc operates using a business model that focuses on the development and commercialization of therapeutics. The company leverages its innovative technology platform to create a diverse pipeline of biologics for the treatment of various diseases. Inhibrx Inc aims to collaborate with strategic partners to advance the development of its pipeline and expand its reach in the healthcare market.
Senti Biosciences Inc is a biotechnology company that develops and commercializes novel therapeutics using synthetic biology and gene editing technology.
Instil Bio Inc operates with a business model focusing on developing and commercializing innovative cell therapy products for the treatment of cancer. They aim to leverage advanced technologies and strategic partnerships to advance their pipeline and bring novel therapies to market.
Sources:
Avalon Globocare Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Avalon Globocare Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
